Inactive

This announcement is to seek qualified manufacturers and/or authorized distributors of Clinical Chemistry Analyzers and Reagents on a Cost Per Tests. Rental and service equipment; reagent commitments-... This announcement is to seek qualified manufacturers and/or authorized distributors of Clinical Chemistry Analyzers and Reagents on a Cost Per Tests. Rental and service equipment; reagent commitments-per tests; calibrators; consumables and controls are necessary to ensure the continuity of operations of essential patient testing results currently being performed at the Department of Pathology and Area Laboratory Services (DPALS). The purpose of this announcement is to gain knowledge of potential qualified sources and their size classification (service-disabled veteran owned small business, veteran owned small business, hub zone, 8(a), small disadvantage business, woman-owned, small business, or large business) relative to North American Industry Classification Code (NAICS) 325413: In-Vitro Diagnostic Substances Manufacturing (size standard of 1,250 employees). Responses to this notice will be used by the Government to make appropriate acquisition decisions. Responses to this notice is not considered to the solicitation announcement. The government will not pay nor reimburse any costs of preparing this response. The Department of Veteran Affairs, Network Contracting Office (NCO) 8, VA Orlando Healthcare System (VAOHS) has the need for a Base of Twelve Months plus Four Twelve months Option Indefinite Delivery Contract for Cost Per Test that includes Automated integrated track system with backup server and Chemistry and immunochemistry analyzers, reagents, controls, calibrators, consumables, preventive maintenance, emergency repairs and extended service. The analyzers will be located at the following VA stations: Orlando VA Hospital at Lake Nona, Daytona VA Outpatient Clinic, and Viera VA Outpatient Clinic. The performance period for this contract Base of Twelve Months plus Four Twelve months Option. Concerns may respond by submitting a qualification letter including the following information: Company Name Capability Statement specific to the technical requirements Please describe how you can provide this requirement to the government. This must not be a generic line card but something that the government can positively use to determine the procurement strategy of this requisition. Company Name: Address: Contract Number: Phone No: CAGE: TIN: DUNS: FSS/GSA Contract Holder, if available: Below is a summary of the reportable tests the equipment must be able to analyze. Â ACETAMINOPHEN ETOH SERUM ALT ETOH URINE AST FENTANYL ALBUMIN GGT ALK PHOS GENTAMICIN AMMONIA GLUCOSE AMPHETAMINES HAPTOGLOBIN AMYLASE HbA1c-WHOLE BLOOD B-HYDROXYBUTYRATE HDL CHOLESTEROL BF GLUCOSE IgA BF LDH IgE BF PROTEIN IgG BARBITURATES IgM BENZODIAZEPINES IRON BILI, DIRECT LDH BILI, TOTAL LACTIC ACID BUPRENORPHINE LIPASE C3 LITHIUM C4 MAGNESIUM CANNABINOIDS METHADONE CARBAMAZEPINE MICROALBUMIN CREATINE KINASE SODIUM-SERUM CARBON DIOXIDE -CO2 SODIUM-URINE CRP-HS OPIATES CSF GLU OXYCODONE CSF PROTEIN PREALBUMIN CALCIUM PHENOBARBITAL CALCIUM URINE PHENYTOIN CHOLESTEROL PHOSPHORUS CHLORIDE POTASSIUM CHLORIDE-URINE POTASSIUM-URINE COCAINE SALICYLATE CREATININE-SERUM THEOPHYLLINE CREATININE-URINE TOTAL PROTEIN DIRECT LDL CHOLESTEROL TRANSFERRIN DIGOXIN TOBRAMYCIN TRIGLYCERIDES PROLACTIN URIC ACID SHBG URINE PROTEIN TESTOSTERONE UREA NITROGEN-SERUM TOTAL PSA UREA NITROGEN-URINE TOTAL T4 VALPROIC ACID TOTALT3 AFP TROPONIN I ANTI CCP TSH ANTI HCV VANCOMYCIN B-hCG VIT B12 BNP STAT ** METHOTREXATE* CEA AMIKACIN* CORTISOL TACROLIMUS* FERRITIN CYCLOSPORINE* FOLATE SIROLIMUS* FREE PSA FREE T4 FSH HBsAg HBsAg confirmatory HEP A AB IgG HEP A AB IgM HEP B CORE AB HEP B CORE-IgM HEP B SURF AB iPTH LH